These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1065187)
41. Volumetric bone mineral density in young women with Turner's syndrome treated with estrogens or estrogens plus growth hormone. Bertelloni S; Cinquanta L; Baroncelli GI; Simi P; Rossi S; Saggese G Horm Res; 2000; 53(2):72-6. PubMed ID: 10971092 [TBL] [Abstract][Full Text] [Related]
42. [Growth hormone therapy in Turner's syndrome: analysis of the effect of therapy on the final height]. Rosenfeld R Probl Endokrinol (Mosk); 1994; 40(2):68-71. PubMed ID: 8197099 [No Abstract] [Full Text] [Related]
44. How should the short stature of girls with Turner's syndrome be treated? Stanhope R J Pediatr Endocrinol Metab; 2002 Feb; 15(2):127-8. PubMed ID: 11874176 [No Abstract] [Full Text] [Related]
45. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome. Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126 [TBL] [Abstract][Full Text] [Related]
46. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome. Cacciari E; Mazzanti L J Clin Endocrinol Metab; 1999 Dec; 84(12):4510-5. PubMed ID: 10599710 [TBL] [Abstract][Full Text] [Related]
47. Does growth-hormone supplementation affect adult height in Turner's syndrome? Taback SP; Collu R; Deal CL; Guyda HJ; Salisbury S; Dean HJ; Van Vliet G Lancet; 1996 Jul; 348(9019):25-7. PubMed ID: 8691926 [TBL] [Abstract][Full Text] [Related]
48. Spontaneous pubertal development in Turner's syndrome. Italian Study Group for Turner's Syndrome. Pasquino AM; Passeri F; Pucarelli I; Segni M; Municchi G J Clin Endocrinol Metab; 1997 Jun; 82(6):1810-3. PubMed ID: 9177387 [TBL] [Abstract][Full Text] [Related]
49. Efficacy of long-term growth hormone treatment in Turner's syndrome. European Study Group. Van den Broeck J; Van Teunenbroek A; Hokken-Koelega A; Wit JM J Pediatr Endocrinol Metab; 1999; 12(5):673-6. PubMed ID: 10703540 [TBL] [Abstract][Full Text] [Related]
50. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol. Gravholt CH; Naeraa RW; Fisker S; Christiansen JS J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336 [TBL] [Abstract][Full Text] [Related]
51. Growth hormone secretion in patients with Turner's syndrome as determined by time series analysis. Wit JM; Massarano AA; Kamp GA; Hindmarsh PC; van Es A; Brook CG; Preece MA; Matthews DR Acta Endocrinol (Copenh); 1992 Jul; 127(1):7-12. PubMed ID: 1519426 [TBL] [Abstract][Full Text] [Related]
52. Turner's syndrome with XO/XXp- karyotype: a case report. Koller AB; Rubin A S Afr Med J; 1976 Sep; 50(38):1484-6. PubMed ID: 973169 [TBL] [Abstract][Full Text] [Related]
53. [Turner's syndrome is not what it was in the past]. Pierson M; Leheup B Arch Fr Pediatr; 1992 Mar; 49(3):149-52. PubMed ID: 1376983 [No Abstract] [Full Text] [Related]